David Hokanson

David Hokanson is a Principal Scientist at Pfizer, specializing in Molecular Biology, Protein Biochemistry, Cell Biology, and Drug Discovery. They possess extensive experience in high-throughput screening for various therapeutic targets and have collaborated with numerous academic, industry, and small start-up partners. Prior to their current role, David held positions as a Senior Scientist at Xtal BioStructures Inc. and a Postdoctoral Research Associate at Cornell University, where they conducted significant research on GTPases. David earned a B.S. in Biochemistry & Bios Pre-Medicine from Ohio University and a Ph.D. in Biochemistry and Molecular Biophysics from the University of Pennsylvania.